Lindenwold Advisors Merck & Co., Inc. Transaction History
Lindenwold Advisors
- $187 Million
- Q2 2024
A detailed history of Lindenwold Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lindenwold Advisors holds 14,077 shares of MRK stock, worth $1.42 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
14,077
Previous 14,173
0.68%
Holding current value
$1.42 Million
Previous $1.87 Million
6.84%
% of portfolio
0.93%
Previous 1.0%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,802Shares Held
1.92BCall Options Held
13.4MPut Options Held
10.6M-
Vanguard Group Inc Valley Forge, PA245MShares$24.6 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$11.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.3 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$5.74 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $255B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...